
Portfolio Highlight
Fuse Oncology: Reducing Friction in One of Healthcare's Most Operationally Complex Specialties
Radiation oncology is a highly technical, multidisciplinary specialty in which operational complexity is inseparable from patient care. Every episode involves coordination across consultation, simulation, contouring, planning, quality assurance, scheduling, physician review, and delivery. In that setting, workflow friction is not a minor inconvenience. It influences time to treatment, staff burden, resource utilization, and the overall experience of both patients and care teams. Companies that can reduce this friction are solving real and persistent problems.
Fuse Oncology is designed for this environment. The company focuses on workflow and operations in radiation oncology, with the goal of streamlining processes, accelerating time to treatment, and improving practice efficiency. That is compelling because much of the burden in the specialty is hidden in handoffs, task tracking, scheduling logic, data movement, and communication among different members of the care team. These are not glamorous problems, but they are mission-critical ones.
At Totipotent, we like healthcare software that is rooted in a clearly understood operating pain point rather than in generic digitization. Fuse Oncology reflects that approach. It is positioned in a specialty where the customer already knows the problem is real. The value proposition does not depend on inventing urgency. It depends on building a product that fits the workflow credibly, reduces burden in practical ways, and becomes part of the operating fabric of the department.
The company also fits a broader Totipotent theme around healthcare efficiency. We believe some of the most durable value in healthcare technology comes from making complex systems function better. In specialties like radiation oncology, even modest improvements in coordination and throughput can have meaningful effects on access, patient flow, staff experience, and enterprise performance. That makes the category especially interesting when the product is designed with genuine domain fluency.
Domain specificity matters here. Generic healthcare tools often struggle when they encounter the realities of specialty care. Radiation oncology requires a product that understands the field's precision, sequencing, and multidisciplinary dependencies. That context can create a real advantage for a focused company because specialty practices are more likely to adopt solutions that feel native to the environment rather than imposed from the outside.
Fuse Oncology belongs in our portfolio because it represents practical, high-relevance innovation. It is improving a real operating environment, not just adding another layer of software. It reflects our view that specialty-focused workflow enablement can create meaningful strategic value when it is built with enough insight into how care is actually delivered.
Why We Invested Fuse Oncology
We invested in Fuse Oncology because radiation oncology is a highly complex specialty where operational friction affects both provider efficiency and patient care. The specialty depends on coordination across many steps and stakeholders, making workflow software especially valuable when it is designed with genuine domain understanding. Fuse is working on a real problem that customers already know they have. The company fits our view that healthcare software creates the most value when it improves how care is actually delivered, not merely how it is documented. We were attracted to the product's relevance in a specialized, high-stakes environment and to the broader thesis that specialty-focused workflow enablement can become strategically important when it reduces burden and improves time to treatment.
